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Mutation of E2F2 in Mice Causes
Enhanced T Lymphocyte Proliferation,
Leading to the Development of Autoimmunity
Introduction
The decision by a cell to choose between entry into the
cell cycle to proliferate, to remain quiescent, or to die
is crucial to an organism. Dysregulation of this decision
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can result in a failure of important reparative, inflamma-Michael E. Greenberg,2 and Ana M. Zubiaga1,6
tory, or other adaptive responses, or the aberrant prolif-1Department of Animal Biology and Genetics
eration characteristic of cancer and autoimmune dis-Faculty of Sciences
eases. Cell cycle entry is primarily regulated in late G1University of the Basque Country
at the restriction point. A number of biochemical eventsBilbao, E-48080
occur coincident with the restriction point which haveSpain
been linked together in a model for cell cycle control.2 Division of Neuroscience
Activation of cyclin/cdk kinases results in phosphoryla-Children’s Hospital and
tion of Rb, causing its dissociation from E2F. Free E2FDepartment of Neurobiology
then activates the expression of DNA synthesis- andHarvard Medical School
G1/S-regulatory genes (Weinberg, 1995). In addition toBoston, Massachusetts 02115
preventing E2F-mediated transcriptional activation, Rb3 NEIKER
can also actively repress transcription from promotersBasque Institute for Agrarian
carrying E2F binding sites by binding to DNA-boundResearch and Development
E2F and recruiting the histone deacetylase HDACIDerio, E-48160
(Brehm and Kouzarides, 1999).4 Department of Immunology and Oncology
The E2F gene family includes at least seven distinctCentro Nacional de Biotecnologı´a/CSIC
proteins that bind DNA as heterodimers with membersUniversidad Auto´noma de Madrid
of the DP protein family (Nevins, 1998; Dyson, 1998;Cantoblanco, E-28049
Helin, 1998; Macleod, 1999). Among the E2F familySpain
members, certain biochemical and functional differ-5 Division of Hematology/Oncology
ences have been reported, though it is not yet clearChildren’s Hospital
whether the E2F proteins execute distinct functions inHoward Hughes Medical Institute and
normal cells and to what degree their functions overlapDana Farber Cancer Institute
(Nevins, 1998). The E2F family of proteins can be dividedBoston, Massachusetts 02115
into three different subgroups based on sequence simi-
larity as well as functional roles. E2Fs 1, 2, and 3 are
related by sequence, are similarly regulated by mito-
Summary gens, bind almost exclusively to Rb, and share the ca-
pacity to induce efficient S phase entry in quiescent
E2Fs are important regulators of proliferation, differ- cells when overexpressed (Johnson et al., 1993; Lukas
entiation, and apoptosis. Here we characterize the et al., 1996; DeGregori et al., 1997; Sardet et al., 1997).
phenotype of mice deficient in E2F2. We show that On the other hand, a second subgroup of E2Fs, E2F4
E2F2 is required for immunologic self-tolerance. and E2F5, are not regulated by cell growth, are poor
E2F2/ mice develop late-onset autoimmune fea- transcriptional activators, and only weakly induce S
tures, characterized by widespread inflammatory infil- phase (Mu¨ller et al., 1997; Verona et al., 1997), sug-
trates, glomerular immunocomplex deposition, and gesting that they are repressors of E2F-responsive
anti-nuclear antibodies. E2F2-deficient T lymphocytes genes (Dyson, 1998; Helin, 1998). An alternate version
exhibit enhanced TCR-stimulated proliferation and a of E2F3, named E2F3b, may also be included in this
subgroup (Leone et al., 2000; He et al., 2000). The thirdlower activation threshold, leading to the accumula-
subgroup of E2F proteins includes E2F6, which lackstion of a population of autoreactive effector/memory
an activation domain and has been shown to competeT lymphocytes, which appear to be responsible for
for binding to E2F promoter sites and thereby represscausing autoimmunity in E2F2-deficient mice. Finally,
transcription (Dyson, 1998; Helin, 1998; Macleod, 1999).we provide support for a model to explain E2F2’s unex-
The generation of mouse strains carrying targetedpected role as a suppressor of T lymphocyte prolifera-
mutations for individual E2F family members has beention. Rather than functioning as a transcriptional acti-
crucial to elucidate the function of these proteins in vivo.vator, E2F2 appears to function as a transcriptional
These mouse models confirm that individual membersrepressor of genes required for normal S phase entry,
of the E2F subgroups have very different biologicalparticularly E2F1.
properties that do not merely reflect their pattern of
expression. However, it is unclear how these differences
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relate to the target specificity of the different E2Fs in7 Present address: Harvard Institutes of Medicine, Beth Israel Dea-
vivo. Mutation of genes included in the first subgroupconess Hospital, and Division of Endocrinology, Massachusetts
of E2F proteins, E2F1 and E2F3, result in mice withGeneral Hospital, Harvard Medical School, Boston, Massachusetts
02115. defects in cell cycle regulation. Notably, E2F3 is required
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for the normal cell cycle-dependent activation of numer- the E2F2/ genotype (Figure 1C) appeared at a fre-
quency close to the expected Mendelian frequency: 97ous E2F-responsive genes of both primary and tumor
were/, 172 were/ and 82 were/ (2  1.42cells. E2F3-deficient mice demonstrate that E2F3 is par-
5.99, p0.05), indicating that all genotypes were equallyticularly crucial for normal fibroblast proliferation and
viable. The E2F2/ mice survived to adulthood, wereresults in an embryonic lethal phenotype (Humbert et
fertile, and produced normal offspring. We confirmedal., 2000). Mutation of E2F1 reveals that it normally func-
by Northern analysis that the targeted mutation in thetions as a promoter of apoptosis, particularly in devel-
E2F2 gene abolishes its expression in these animalsoping thymocytes, and as a tumor suppressor possibly
(Figure 1D).via its role as a promoter of apoptosis (Field et al., 1996;
Yamasaki et al., 1996, 1998).
Aged E2F2-Deficient Mice DieThe third member of this E2F subgroup, E2F2, was
of Systemic Autoimmune Diseaseoriginally identified by low-stringency hybridization as
Both the gross and microscopic morphology of organsan E2F1-related gene, together with E2F3 (Kaelin et al.,
from 4- to 8-week-old E2F2/ mice were normal (data1992; Ivey-Hoyle et al., 1993), and it shows high se-
not shown). However, by 15 months of age 67% of thequence homology with E2F1 and E2F3. Similar to E2F1
wild-type animals were alive and apparently healthy,and E2F3, ectopic expression of E2F2 promotes S phase
whereas only 27% of the E2F2-deficient animals hadentry in quiescent immortalized rat fibroblasts through
survived to this age. To better ascertain the age-depen-the activation of target genes important at the G1/S
dent abnormalities in the E2F2-deficient mice, fourtransition (Lukas et al., 1996; DeGregori et al., 1997).
E2F2-deficient and five wild-type littermates were sacri-Other experiments have shown that E2F2 has oncogenic
ficed at 15 months of age. Remarkably, all of the E2F2-activity (Wu and Levine, 1994). Furthermore, E2F2 gene
deficient mice, but none of the wild-type littermates,activity is induced during a proliferative response, lead-
exhibited features of marked autoimmune disease.ing to an accumulation of E2F2 coincident with S phase
All of the aged E2F2-deficient mice displayed grossentry (Ikeda et al., 1996). These results suggest that E2F2
splenomegaly, with spleen size two to five times highermay be necessary at the G1/S transition to promote cell
than that in wild-type littermates. Spleen histology dem-cycle progression. However, recent studies indicate that
onstrated white pulp hyperplasia and increased sinusoi-E2F2 can also trigger apoptosis under certain conditions
dal cellularity (Figures 2A and 2B), characteristic of im-(Vigo et al., 1999). It is presently unknown whether E2F2
mune hyperreactivity. Several different organs fromplays either or both functions in vivo. Furthermore, al-
elderly E2F2-deficient mice accumulated inflammatorythough many transcriptional targets are common to E2F1,
infiltrates, although the organs from age-matched wild-E2F2, and E2F3, target specificity has also been reported
type control mice did not. Infiltrates of mononuclearfor each gene (DeGregori et al., 1997; Vigo et al., 1999;
cells were consistently observed in the lungs of elderlyMu¨ller et al., 2001). The different target specificity sug-
E2F2-deficient mice (Figure 2C). Likewise, the livers ofgests that E2F2 could play a unique role in vivo that is
elderly E2F2-deficient mice exhibited numerous peri-not shared by other members of the E2F family.
vascular infiltrates (Figure 2D). The aged E2F2-deficientTo assess the function of E2F2 in normal growth and
mice also demonstrated evidence of skin abnormalitiesdevelopment and to test the role of E2F2 in the regulation
consisting of considerable hair loss, skin wounds, andof proliferation, apoptosis, and/or differentiation in vivo,
erythema affecting the head and neck region, reminis-we have inactivated the E2F2 locus in mice by homolo-
cent of some autoimmune/inflammatory diseases (Fig-gous recombination. Mice lacking E2F2 are viable, yet
ure 2F). The observed skin changes were not found inthey exhibit defects in T lymphocyte homeostasis lead-
any of the wild-type control mice.ing to a lupus-like autoimmune disorder. E2F2-deficient
Histology of the kidneys of elderly E2F2-deficient miceperipheral T lymphocytes exhibit enhanced proliferation
demonstrated a membranoproliferative glomerulone-
upon TCR-mediated stimulation, as well as a lower
phritis that was focal and of moderate intensity. The
threshold for activation. Thus, E2F2 functions in mice
affected glomeruli were enlarged with a thickened base-
as a negative regulator of the immune response by sup- ment membrane and contained perivascular aggregates
pressing cellular proliferation of activated lymphocytes. of inflammatory infiltrates. Immunocomplex deposition
was detected in the affected areas, as determined by
Results immunohistochemical analysis with antibodies to mouse
IgG (Figure 2E). As shown, the E2F2-deficient kidneys
Targeted Mutation of the E2F2 Gene in Mice contain prominent immune complex deposition, in sharp
To study the function of E2F2, we generated mice defi- contrast to the wild-type kidneys, which do not contain
cient in E2F2 by gene targeting, using the strategy de- these complexes.
picted in Figure 1 and Experimental Procedures. One We also assayed serum from elderly wild-type and
ES cell line produced high percentage chimeras and E2F2-deficient mice for the presence in the serum of
was used to produce mice heterozygous for the E2F2 anti-dsDNA antibodies. Notably, the titer of IgG antibody
mutation. Heterozygous mice carrying a null E2F2 allele against dsDNA observed in the E2F2-deficient mice cor-
were maintained in a mixed (C57Bl/6129/Sv) genetic related with the severity of the autoimmune organ dam-
background in all experiments described here. The het- age observed in those mice and was significantly higher
erozygotes appeared completely normal in their health than in wild-type controls (relative OD values for E2F2/
and appearance and behaved similarly to wild-type in mice, 4.2, 1.9, and 0.3, versus relative OD values for
all assays described below (data not shown). When E2F2 wild-type control mice, 0.3 in all cases; relative OD
value of MRL-lpr positive control serum, 4.6).heterozygotes (E2F2/) were intercrossed, animals of
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Figure 1. Mutation of the E2F2 Gene
(A) Map of exon 3 (box) and surrounding intronic sequences of mouse E2F2. Restriction enzyme recognition sites are abbreviated as follows:
S, SacI; H, HindIII; Bx, BstXI; and C, ClaI.
(B) Southern hybridization using an E2F2 genomic probe (as depicted in [A]) demonstrates the presence of the targeted mutation in ES cell
lines. The use of a probe for neo sequences indicated that additional copies of the gene targeting construct do not exist elsewhere in the
genome (data not shown).
(C) A genomic PCR was performed to genotype all progeny. PCR primer positions are indicated in (A).
(D) Northern hybridization showing 5.0 kb band in / thymocytes corresponding to the E2F2 mRNA, which is absent in the E2F2/
thymocytes. The integrity and amount of RNA in each lane was demonstrated by visualizing the 28S RNA band after ethidium bromide staining.
Taken together, the pathological features observed in syndrome observed in E2F2-deficient mice prompted
us to consider if E2F2 is also required for normal thymicaged E2F2-deficient mice resemble features found in
human and murine autoimmune syndromes. The devel- negative selection. Thymuses from E2F2/ mice were
found to contain a higher fraction of mature thymocytesopment of an autoimmune syndrome in E2F2-deficient
mice suggests that E2F2 plays a normal role in vivo in (CD4 or CD8) than thymuses from wild-type lit-
termates (p  0.001), especially of the CD8 subsetthe maintenance of immunologic tolerance.
(Figure 3A), with a concomitant decrease in immature
double-positive (DP) CD4/CD8 thymocytes. To testAccentuated Autoimmunity in Male E2F2-Deficient
Mice Expressing the Anti-H-Y Transgene whether E2F2 is required for normal thymic negative
selection (central tolerance), we introduced the E2F2E2F1 is required for normal thymic negative selection
(Zhu et al., 1999; Garcı´a et al., 2000). The autoimmune mutation into a more informative genetic background:
Immunity
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Figure 2. Features of Autoimmune Disease in Older E2F2-Deficient Mice
Organs from wild-type and E2F2/ mice 15 months of age were harvested and processed as described in Experimental Procedures.
(A and B) Photomicrographs of spleens (40) stained with hematoxilin-eosin (H-E). Note the hyperreactive white pulp and the effacement of
the normal spleen histology in E2F2/ mice (B), compared to the normal spleen histology of a wild-type mouse (A).
(C) Lung (50) from an E2F2/ mouse stained with H-E showing inflammatory infiltrates surrounding vessels and bronchioli.
(D) Liver (50) from an E2F2/ mouse stained with H-E showing perivascular infiltrates of mononuclear cells.
(E) Typical IgG deposits in glomeruli of E2F2/ kidneys (150) as shown after staining kidney cryosections with anti-IgG-FITC monoclonal
antibody (mAb).
(F) Skin lesions in E2F2/ mice (center and right), compared to age-matched E2F2/ mouse (left).
a mouse line carrying a transgene for a T cell receptor matory/autoimmune disorder similar to those seen in 15-
month-old E2F2-deficient mice, although more severe,specific for male antigen, H-Y (Kisielow et al., 1988). In
E2F2/ Tg male mice, cell number in the thymus was affecting mainly the spleen, liver, and skin (data not
shown). By contrast, no overt signs of inflammatory dis-reduced similarly to E2F2/ Tg mice. Likewise, the
proportion of CD4/CD8 thymocytes was severely re- ease were detected in Tg/E2F2/ male mice or Tg/
E2F1/ male mice (Garcı´a et al., 2000).duced, again similar to wild-type (Figure 3B). Thus, we
conclude that mutation of E2F2 does not impair thymic The presence of a severe autoimmune syndrome in
these mice, despite intact thymic negative selection,negative selection.
Although thymocyte development appeared normal points to a defect in peripheral mechanisms of self-
tolerance caused by the E2F2 mutation. Even with intactin E2F2-deficient Tg male mice, these mice became
increasingly sick by 4 months of age and died by 5–7 thymic negative selection, a small number of self-reac-
tive thymocytes normally escape negative selectionmonths of age. By contrast, control E2F2/ Tg male
mice remained healthy appearing to at least 12 months (Van Parijs and Abbas, 1998). Presumably, a failure of
peripheral mechanisms of self-tolerance allows theseof age. A detailed analysis of 5-month-old male mice
revealed a number of features consistent with an inflam- self-reactive lymphocytes to generate autoimmunity in
Autoimmune Disease in E2F2-Deficient Mice
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Figure 3. Normal Negative Selection but In-
crease in the Number of Proliferating E2F2/
T Lymphocytes Carrying a Self-Reactive
TCR-Transgene (Anti-HY)
(A) Thymocyte expression of the CD4 and
CD8 cell surface antigens. Thymocytes from
wild-type (n  10) and E2F2/ mice (n  10)
were double labeled with anti-CD4-FITC and
anti-CD8-PE mAbs and analyzed by flow cy-
tometry. The numbers in each quadrant rep-
resent the mean percentage of cells in that
quadrant.
(B) Thymocytes from E2F2/ Tg and
E2F2/ Tg male mice were labeled as in (A).
The experiment shown is representative of
two experiments (n  4 /; n  4 /).
(C and D) Lymph node cells from transgenic
E2F2/ and E2F2/ male mice were double
stained with anti-V8.2-FITC and anti-CD8-
PE mAbs (C) or with T3.70-biotin antibody,
which recognizes the transgenic TCR V
chain, and anti-CD8-FITC mAbs (D) and ana-
lyzed by flow cytometry. The experiment
shown is representative of three experiments
(n  6 /; n  6 /).
(E) In vivo BrdU labeling of transgenic E2F2/
(n  2) and E2F2/ (n  2) male mice, fol-
lowed by an incubation of splenocytes with
anti-BrdU-FITC and anti-CD8-PE mAbs, as
described in Experimental Procedures.
the E2F2-deficient mice. The accelerated pace of auto- of lymph nodes and spleen from anti-H-Y transgenic
mice revealed a 2- to 3-fold increase in the proportionimmunity when the E2F2 deficiency is in the background
of the anti-H-Y transgene in male mice presumably re- of H-Y-specific CD8 T cells in E2F2 mutant animals
compared to wild-type controls, as detected by clono-flects the fact that in these mice most T cells that survive
to the periphery express an anti-self TCR, specifically typic mAbs specific for the V8.2 chain and the V3
chain of the transgenic receptor (Figures 3C and 3D).the anti-H-Y TCR (V8.2/V3).
Considering the fact that E2F2/ Tg male mice also
develop marked splenomegaly, the absolute number ofExpanded Memory T Cell Population
potentially self-reactive peripheral T cells was dramati-Due to E2F2 Deficiency
cally increased in the E2F2/ mice.We reasoned that the accelerated pace of autoimmunity
We measured the proliferation of these V8/CD8in anti-H-Y E2F2/ Tg mice would facilitate the analy-
sis of the tolerance defect in these mice. Examination “antigen-primed” cells directly in vivo. To label cells in
Immunity
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S phase, E2F2/ Tg and E2F2/ Tg mice were given induced proliferation parallels the expansion of the
BrdU. These experiments demonstrated a striking in- CD44hi/CD69 lymphocyte population, confirming that
crease in the percentage of proliferating CD8 T cells these are effector/memory cells.
in E2F2/ Tg mice compared to E2F2/ Tg controls, To more directly examine whether T cells from E2F2/
indicating that a substantial proportion of V8/CD8 mice were autoreactive, we performed a syngeneic
T lymphocytes were activated in vivo in the E2F2 mutant mixed lymphocyte reaction using irradiated autologous
mice (Figure 3E). splenocytes as stimulators (Suzuki et al., 2001). Lymph
Since the original E2F2-deficient mice (not expressing node-derived T cells from E2F2/ mice responded with
a TCR transgene) develop similar autoimmune features, enhanced proliferation relative to T cells from wild-type
albeit more slowly, we examined their peripheral im- animals when cultured in the presence of syngeneic
mune system to look for evidence of a similar expansion stimulator cells. Therefore, E2F2/ T lymphocytes are
of the antigen-primed T cell population. We examined functionally autoreactive (Figure 4E). Thus, based on
E2F2-deficient and wild-type littermates at several ages. the observed characteristic inflammatory infiltrates, the
The submandibular, axillary, and inguinal lymph nodes abnormal accumulation of effector/memory cells, the
of E2F2-deficient mice were of similar size and cellularity production of anti-dsDNA antibodies, and the presence
as those from wild-type littermates at all ages (24.1  of anti-self T cells in a syngeneic MLR, we conclude that
106	 6.8  106 in wild-type versus 22.3  106	 4.4  E2F2-deficient mice develop an autoimmune disease.
106 in E2F2/ mice). The spleens of E2F2/ mice were
of comparable size to wild-type at 4 weeks of age but Augmented TCR-Stimulated Proliferation
appeared significantly enlarged (more than 2-fold) by of E2F2-Deficient T Cells
8–12 weeks of age (1,445 	 250 mg in E2F2/ mice To investigate the mechanisms by which E2F2-deficient
versus 668	 108 mg in E2F2/mice) and, as mentioned mice develop autoimmunity, functional studies of lympho-
above, continued to enlarge relative to wild-type through cytes from E2F2/ and wild-type mice were performed.
15 months of age (3,340 	 540 mg in E2F2/ mice We first determined whether E2F2 plays a role in lympho-
versus 722 	 125 mg in E2F2/ mice). cyte proliferation. T lymphocytes were stimulated with
The ratio of T to B cells was normal in both the lymph increasing concentrations of an activating antibody
nodes and the spleen. However, an increased percent- against CD3, and DNA synthesis was measured by
age of CD8 T cells relative to CD4 T cells was found [3 H]thymidine incorporation 3 days later. As shown in
in the lymph nodes and spleen of E2F2-deficient mice Figure 5A, the incorporation of [3 H]thymidine was signifi-
compared to wild-type littermates (CD4/CD8 ratio: cantly higher in E2F2/ T cells compared to wild-type
1.43 	 0.3 wild-type versus 0.79 	 0.1 E2F2/) (data controls (p 0.01). Importantly, this response was more
not shown). No B220/Thy cells or CD4/CD8 cells, marked at suboptimal concentrations of anti-CD3, sug-
which are greatly accumulated in autoimmune lpr mice, gesting a lower activation threshold in E2F2/ T cells.
were found in the lymphoid organs of E2F2/mice (data To prove that the enhanced proliferation was intrin-
not shown). sic to naive T cells and was not merely a reflection of
Next, we analyzed the expression of the lymphocyte
the expanded population of effector/memory cells in
activation/memory markers. The fraction of CD8 or
E2F2/ mice, we performed an experiment designed
CD4 T cells that expressed high levels of CD44 was
to measure the proliferation of purified naive T lympho-
similar between wild-type and E2F2/ at 3–4 weeks of
cytes. For this experiment, we took advantage of the
age. By 6–8 weeks of age, the CD8 T cell subset in
fact that the number of CD44hi cells is similar to wild-E2F2-deficient mice showed an increased population
type in 4-week-old mice and that the expansion of thisof CD44hi lymphocytes relative to wild-type littermates.
population occurs primarily among the CD8 populationThis CD44hi population had expanded further at 15
of T cells. Thus, we purified CD8 T lymphocytes frommonths of age (Figure 4A). The CD4 T lymphocyte pop-
4-week-old E2F2/ mice and littermate controls andulation of E2F2/ mice also exhibited an increase in the
examined their ability to proliferate in response to stimu-CD44hi population, which was easily detected in lymph
lation with anti-CD3. Neither purified E2F2/ nor wild-nodes and spleens of 15-month-old mice but not in
type lymphocytes contained detectable CD44hi cellsyounger mice (Figure 4B). On the other hand, the number
(data not shown). As shown in Figure 5B, naive E2F2/of cells expressing high levels of CD69 was only moder-
T lymphocytes exhibited augmented proliferation rela-ately increased in E2F2-deficient mice (Figure 4C). Fur-
tive to wild-type controls, similar to that seen with unpu-thermore, the number of CD69 cells did not increase
rified T cells. These results indicate that E2F2-deficientsubstantially in older mice. Thus, the majority of the
naive T cells have an intrinsic proliferative advantageCD44hi lymphocytes that accumulate in the lymphoid
and suggest that E2F2 functions as a negative regulatororgans in E2F2/ mice are CD69, identifying them as
of T cell proliferation. The enhanced proliferation of na-cells with the effector/memory phenotype.
ive E2F2 mutant T cells may account, at least in part,To demonstrate more conclusively that the expanded
for the accumulation of effector/memory cells in E2F2-population of lymphocytes in E2F2/ mice represents
deficient mice.effector/memory cells, we examined their ability to pro-
To determine whether the enhanced [3 H]thymidine in-liferate in response to IL-2 in the absence of any signals
corporation observed in E2F2/ T cells truly repre-delivered through the antigen receptor (London et al.,
sented an increase in the frequency of cells traversing1999). We found an increase in E2F2/ lymphocyte pro-
the cell cycle rather than enhanced survival, we directlyliferation in response to IL-2 relative to wild-type (Figure
measured the fraction of cells in S phase and the fraction4D), which increases with age from twice that of wild-
undergoing apoptosis. Thus, we stimulated 6- to 8-week-type in 8- to 12-week-old animals to 13 times that of
wild-type in 15-month-old mice. The increase in IL-2- old wild-type or E2F2-deficient lymph node cells with
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Figure 4. Expanded Memory T Cell Popula-
tion Due to E2F2 Deficiency
(A and B) Lymph node cells harvested from
E2F2/ and age-matched E2F2/mice were
double stained with anti-CD44-FITC and anti-
CD8-SPRD mAbs (A) or anti-CD44-FITC and
anti-CD4-PE mAbs (B) and analyzed by flow
cytometry. Histograms show proportions of
CD8 or CD4 lymph node cells with CD44hi
expression from 8- to 12-week-old mice
(n 5/; n 5/) or 15-month-old mice
(n  4 /; n  4 /). Histogram values
in this and subsequent figures indicate the
mean 	 SEM.
(C) Expression of CD69 activation marker in
lymph nodes double labeled with anti-CD69-
FITC and anti-CD4-PE mAbs.
(D) Increased response to IL-2 in E2F2/
mice. Lymph node cells were stimulated with
IL-2 as indicated in Experimental Procedures.
Proliferation is measured by [3 H]thymidine in-
corporation (n 4/; n 4/; two inde-
pendent experiments).
(E) MLR. Responder T cells from E2F2/ or
E2F2/ mice were incubated with stimulator
cells from syngeneic or allogeneic mice. Pro-
liferation was measured as mean thymidine
uptake 	 SEM.
anti-CD3 and measured the fraction of cells in S phase lower than wild-type, whereas the fraction of apoptotic
cells was increased (Figures 5D and 5E). Taken together,(determined by BrdU labeling index) and undergoing
apoptosis (determined by TUNEL staining). As shown these results suggest that E2F1 and E2F2 play different
roles in T lymphocyte function.in Figure 5E, the fraction of cells undergoing apoptosis
was similar between wild-type and E2F2-deficient cells.
By contrast, as shown in Figure 5D, the fraction of cells Normal Response of E2F2-Deficient T Lymphocytes
to Apoptotic Stimulistaining positively for BrdU was significantly higher in
the E2F2-deficient cells. Thus, we conclude that E2F2- We next sought to determine whether E2F2 influences
peripheral T cell survival in response to other stimuli.deficient cells are hyperproliferative compared to wild-
type. E2F2/ and E2F2/ T lymphocytes were equally sus-
ceptible to cell death following anti-Fas or Dex treatment
(data not shown). To test whether accumulation of T cellsImpaired TCR-Stimulated Proliferation
of E2F1-Deficient T Cells with a memory phenotype in E2F2/ mice was due to
a failure in activation-induced cell death, we stimulatedThe unexpected result that E2F2/ T lymphocytes ex-
hibit increased proliferation prompted us to examine the T cells with Con A for 72 hr, followed by exposure to
apoptotic stimuli, including anti-CD3, anti-Fas, serum,proliferation of E2F1-deficient T lymphocytes. Lymph
node T cells from E2F1/ or wild-type mice were stimu- and/or IL2 withdrawal. No significant differences be-
tween E2F2/ and E2F2/ cells were observed in apo-lated with antibodies against CD3, and DNA synthesis
was measured 3 days after antigenic exposure. In con- ptotic responses to any of these treatments (Figure 6).
These results indicate that E2F2-deficient T cells showtrast to the results with E2F2-deficient lymphocytes,
E2F1-deficient T lymphocytes exhibited decreased anti- a normal sensitivity to apoptosis.
CD3-stimulated proliferation compared to wild-type
controls (Figure 5C). Thus, E2F1 gene deficiency results Differential Gene Expression in E2F1/ and E2F2/
T Lymphocytes upon TCR Stimulationin impaired T cell responses, whereas E2F2 gene defi-
ciency results in exaggerated T cell responses. In this Serum stimulation has been found to induce the expres-
sion of E2F1 and E2F2 mRNA in fibroblasts at a timecase, when we analyzed S phase entry and apoptosis of
E2F1/ T cells, the fraction in S phase was significantly that coincides with the transition of cells from G1 into
Immunity
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Figure 5. E2F2/ T Lymphocytes Exhibit a
Proliferative Advantage upon TCR Stimula-
tion, Whereas E2F1/ T Lymphocytes Show
an Impaired Response upon Activation
(A) Unpurified lymph node cells from E2F2/
(n  6) and E2F2/ (n  6) mice were stimu-
lated with anti-CD3, and proliferation rates
were determined by [3 H]thymidine incorpora-
tion. Values represent mean 	 SEM of three
independent experiments.
(B) Lymph node cells from E2F2/ and
E2F2/ mice (n  3 for each genotype) de-
pleted of CD8 cells were stimulated with
anti-CD3, as shown in (A).
(C) Lymph node cells from wild-type, E2F1/,
and E2F2/ mice (n  3 for each genotype)
were stimulated with anti-CD3, as in (A).
(D and E) Lymph node cells from wild-type,
E2F1/, or E2F2/ mice (n  3 for each ge-
notype) were stimulated with anti-CD3. At
various times after stimulation, BrdU incorpo-
ration was measured by flow cytometry (D),
or apoptosis was measured by the TUNEL
assay, followed by flow cytometry (E).
the S (Neuman et al., 1994; DeGregori et al., 1995). The E2F2/ lymph nodes. As shown in Figure 7A, in wild-
type T lymphocytes both E2F1 and E2F2 mRNAs aredistinct T cell responses that we found in E2F1/ and
E2F2/ mice upon TCR-mediated activation prompted expressed after TCR stimulation but with differing kinet-
ics; E2F1 mRNA levels peak 24 hr earlier than E2F2us to examine the expression profiles of these genes in
T lymphocytes obtained from wild-type, E2F1/, and mRNA levels. As with fibroblasts, the timing of expres-
sion of E2F1 coincides with the transition into S phase,
consistent with a role for E2F1 in the activation of the
expression of genes required for DNA replication. By con-
trast, the delayed expression of E2F2 mRNA is not consis-
tent with a role at the onset of S phase but instead might
suggest a role in terminating the proliferative response.
Interestingly, mutation of E2F1 affects the expression
of E2F2, and vice versa. The expression of E2F2 mRNA
is significantly reduced by mutation of E2F1, suggesting
a role for E2F1 as a positive regulator of E2F2 expres-
sion, consistent with previous reports (Sears et al.,
1997). Unexpectedly, mutation of E2F2 results in en-
hanced expression of E2F1, suggesting a negative regu-
Figure 6. Normal AICD in Peripheral T Cells lation of E2F1 expression by E2F2. Similarly, the expres-
Lymph node T cells were activated for 48 hr with Con A prior to sion of Orc-1 mRNA, known to have E2F sites in its
treatment with the following apoptotic stimuli: no serum (A), serum
promoter (Ohtani et al., 1996), appeared to be regulated(B), anti-CD3 10 
g/ml (C), anti-Fas 1.5
g/ml (D), or dexamethasone
positively by E2F1 and negatively by E2F2 (Figure 7A).0.01 M (E). Cell viability was assessed 48 hr later by PI staining
followed by flow cytometry. It has been demonstrated previously that E2F sites in
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Figure 7. E2F2 Mediates Transcriptional Repression of Genes Required for S Phase
(A) Lymph node cells were harvested from 8- to 12-week-old wild-type (n  10), E2F1/ (n  10), and E2F2/ (n  10) mice. Pooled cells
were stimulated with Con A (3 
g/ml), and RNA was purified at the indicated times. Northern blots were sequentially hybridized with DNA
probes to E2F2, E2F1, Orc1, and -actin. E2F1 and E2F2 levels for each time point after being normalized to -actin mRNA levels were as
follows: E2F1 in wild-type cells, 0.4, 1.15, 1.03, 0.76, and 0.5; E2F1 in E2F2/ cells, 0.56, 1.85, 1.2, 1.1, and 0.83; E2F2 in wild-type cells, 0.35,
0.53, 2.28, 3.4, and 1.7; E2F2 in E2F1/ cells, 0.54, 0.42, 1.16, 1.65, and 0.75.
(B) E2F2 negatively regulates E2F1 promoter activity. Exponentially growing Jurkat T cells were transfected with various plasmids as indicated
in Experimental Procedures. Shown are mean luciferase values 	 SEM, normalized to Renilla luciferase activity.
the E2F1 promoter function to negatively regulate the die early due to autoimmune disease with features of
splenomegaly, multiorgan inflammatory infiltrates, glo-expression of E2F1. The enhanced expression of E2F1
merulonephritis, and serum anti-DNA antibodies. E2F2-in the context of E2F2 deficiency suggests that E2F2
deficient T lymphocytes hyperproliferate in response tomay at least partially mediate the repression of E2F1 in
TCR stimulation, indicating that E2F2 functions as aT lymphocytes. We decided to directly test the ability
negative regulator of cellular proliferation. Furthermore,of E2F2 to repress the E2F1 promoter in T cells. For this
in striking contrast to E2F1, E2F2 can function in T lym-purpose, we transfected asynchronously cycling Jurkat
phocytes as a transcriptional repressor of genes con-T cells with an E2F1 promoter-luciferase reporter con-
taining E2F sites, providing a mechanism for E2F2-medi-struct either alone or with E2F1 or E2F2. As shown in
ated suppression of cellular proliferation.Figure 7B, the promoter-reporter alone had significant
Our investigation into the mechanism of autoimmunitybasal activity. Cotransfection of an E2F1 expression
in E2F2-deficient mice has revealed a number of surpris-construct resulted in increased promoter activity, similar
ing results. First, utilizing crosses with anti-H-Y trans-to previously published reports in other cell lines (Neu-
genic mice, we have been able to assess the requirementman et al., 1994). In striking contrast, cotransfection of
for E2F2 for normal thymic negative selection, an importantan E2F2 expression construct resulted in a significant
mechanism for eliminating autoreactive T cells. We andand reproducible decrease in both basal promoter activ-
others have shown previously that E2F1 is required fority and E2F1-stimulated E2F1 promoter activity. Thus,
normal thymic negative selection (Zhu et al., 1999;both in T cells in vitro and in T cells in vivo, we observe
Garcı´a et al., 2000). In contrast, in the absence of E2F2,distinctly opposite roles for E2F1 and E2F2.
thymocyte maturation and negative selection appear to
occur normally. Remarkably, however, the presence of
Discussion the autoreactive transgenic TCR in these mice results
in accelerated autoimmunity. It is worthwhile to note
Examination of mice deficient in E2F2, the last of the Rb- that other gene mutations, including those in CD30 and
specific E2F family members to be purposely mutated in E2F1 that impair normal thymic negative selection and
mice, has led to the identification of important nonredun- lead to an expanded population of anti-self T cells, fail
to result in autoimmune disease in the anti-H-Y geneticdant functions of E2F2. Notably, aged E2F2/ animals
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background (Amakawa et al., 1996; Garcı´a et al., 2000). The similarities and differences in immune function
These findings, together with our data showing that between the E2F1-deficient and E2F2-deficient mice
E2F2 is required for peripheral tolerance, indicate that provide an interesting window on the specialization of
abrogation of peripheral mechanisms of self-tolerance members of a gene family. Both E2F1 and E2F2 play
alone is sufficient to result in autoimmune disease. The important roles in the development of the active T cell
importance of peripheral self-tolerance in suppressing repertoire. E2F1 exerts its influence by promoting the
autoimmunity has been demonstrated in a number of apoptosis of immature thymocytes and promoting the
ways, for example using lpr or gld mice (Singer and proliferation of mature T cells. E2F2, by contrast, exerts
Abbas, 1994; Nagata and Suda, 1995). its influence by suppressing the proliferation of naive
The major pathological features of the autoimmune syn- T cells. Together, the two genes appear to act as cas-
drome displayed by E2F2/ mice are similar to the human settes whose function can be inserted into an appro-
disease systemic lupus erythematosus. Interestingly, re- priate cell at an appropriate time to promote prolifera-
cent genetic analyses of mice and human lupus patients tion, apoptosis, or cell cycle arrest. By functioning in
have identified several lupus susceptibility loci (Shai et different cells and with different timing, these two genes
al., 1999; Gaffney et al., 1998), including one locus that play quite distinct roles in immune function. E2F1 is
contains the human E2F2 gene (1p36). Thus, in addition required for normal thymic negative selection, the thy-
to providing insight into the function of E2F2 and its role mic mechanism of self-tolerance. E2F2 is required for
in the immune system, these mice might prove to be a normal peripheral mechanisms of self-tolerance. To-
useful model for human autoimmune disease. gether, E2F1 and E2F2 appear to function as partners
Our results suggest a straightforward model to explain in a dyad of yin and yang. E2F1 promotes T cell prolifera-
the breakdown in peripheral tolerance observed in tion, while E2F2 suppresses T cell proliferation, perhaps
E2F2/ mice. We find that E2F2-deficient T cells are in part by suppressing E2F1 gene expression. Further-
hyperresponsive to TCR stimulation, responding with more, each functions in its own compartment to maintain
increased proliferation to lower concentrations of ligand. self-tolerance. Together the E2F1-E2F2 dyad regulate
Thus, low levels of self-ligands may be sufficient to trig- the major components of immunologic self-tolerance. It
ger an autoimmune disease in these mice, resulting in remains to be seen to what extent this model of E2F
a dramatic, abnormal expansion of the CD44hi/CD69 gene function will explain other abnormalities observed
effector/memory population of T cells. In fact, this in mice deficient in one or more E2F family of genes.
expansion of the effector/memory population of T cells
Experimental Proceduresis a common feature in mice with autoimmune pheno-
types and has also been found in mice with mutations
E2F2-Targeting Vector Construction, Embryonicin CTLA-4, IL2R, Pten, p21, p65PI3K, and PD-1 (Tivol et
Stem Cell Culture, and Embryo Manipulational., 1995; Waterhouse et al., 1995; Suzuki et al., 1995;
A murine E2F2 genomic clone was isolated from a 129/Sv genomic
Di Cristofano et al., 1999; Nishimura et al., 1999; Balo- library using a hybridization probe prepared from an E2F1 cDNA
menos et al., 2000; R-Borlado et al., 2000). fragment (Kaelin et al., 1992). In addition to the E2F1-containing
The enhanced TCR-stimulated proliferation of positives, several plaques were isolated containing crosshybridizing
DNA that corresponded to E2F2 (Ivey-Hoyle et al., 1993; Lees et al.,E2F2/ T cells suggests that, contrary to expectation,
1993). A 3.7 kb fragment containing an exon encoding the DNA bindingE2F2 normally functions to suppress proliferation in na-
and activation domain was subcloned into pBlueScript KS(). To gen-ive T cells. To date E2F family members have been
erate a gene-targeting vector, a fragment containing PGK-neo wasimplicated as promoters of proliferation. For example,
inserted by blunt-end ligation into the BstXI site within the E2F2 exon.
mutation of E2F1 leads to decreased T lymphocyte pro- The disrupted E2F2 genomic fragment was then inserted into a
liferation (Figure 5), and mutation of E2F3 leads to im- backbone containing a PGK-TK gene to provide a negative se-
paired fibroblast proliferation (Humbert et al., 2000). In- lectable marker, as previously described (Field et al., 1996).
J1 ES cell culture and injection of ES cells into host blastocyststerestingly, however, the combined loss of E2F1 and
was performed as previously described (Field et al., 1996).E2F2 leads to increased T cell proliferation, suggesting
that simultaneous deficiency of E2F1 and E2F2 activity
Southern Hybridization, PCR, and Northern Hybridizationresults in loss of negative function that is dominant to DNA isolated from the offspring of chimeras and subsequent gener-
the loss of positive functions (Zhu et al., 2001). ations was digested with HindIII and used in standard Southern
E2F2, in contrast to other E2F family members, may blots, as previously described (Field et al., 1996), using a probe
play a crucial role in Rb-mediated repression of genes prepared from E2F2 genomic sequences to determine the geno-
types of the mice.required for S phase entry, for example, by acting to
A genomic PCR assay to detect the wild-type allele (350 bp) ortether Rb to specific E2F promoter sites. Evidence for
the mutant E2F2 allele (250 bp) was designed using a commonthis model is provided by the observation that, upon
5 exon primer (TACTGTTCCTGGCCCCGC) and a 3 exon primer
stimulation, E2F2-deficient T cells express increased (TGGAGAGACCCCAGGCTG) or a neoR gene primer (CAAGTGC
levels of E2F1 and Orc1 mRNA compared to their wild- CAGCGGGGCTGCTAAAG). PCR reactions were amplified with Taq
type counterparts. Furthermore, E2F2 can specifically polymerase (PE Biosystems) and analyzed on a 1.5% agarose gel.
repress E2F1 promoter activity in T cells in vitro. Thus, Wild-type and mutant E2F1 alleles were detected as previously de-
scribed by PCR (Garcı´a et al., 2000).in T cells, E2F2 may be the crucial E2F for Rb-mediated
For Northern hybridization, cells were isolated as indicated below,gene repression. Possibly the overexpression of E2F1
and RNA was purified using the TRIzol RNA isolation system (Lifeor Orc1 alone is sufficient to account for the enhanced
Technologies, Inc). The cDNAs used as probes for Northern analyses
proliferation of E2F2-deficient T cells. However, the en- were: mouse E2F2 (a 0.6 kb EcoRI fragment), human E2F1 (a 0.9 kb
hanced expression of these genes may be merely a SalI-EcoRI fragment), mouse Orc1 (a 2.6 kb HindIII fragment), and
sentinel for a myriad of proliferation-promoting genes -actin (a 1.3 kb HindIII-EcoRI fragment). The levels of mRNA expres-
sion were visualized and quantitated by a Molecular Imager (BioRad).that rely upon E2F2 for Rb-mediated repression.
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In Vitro Lymphocyte Stimulation and Death Assays ization, M.C. Moreno-Ortiz for assistance with flow cytometry, M.I.
Garcı´a for technical help, U. Larizgoiti for help in luciferase assays,Thymuses, lymph nodes, and spleens were harvested and purified
from wild-type, E2F1/, and E2F2/ mice as previously described and I. Garcı´a and A. Iglesias for help with mice. We are grateful to
Dr. Farnham, Dr. Kaelin, Dr. Zisimopoulou, and Dr. Rocha for kindly(Field et al., 1996) with minor modifications. To purify a CD8 lym-
phocyte population, lymph node cells were incubated with biotinyl- providing us plasmids and reagents. We also thank Dr. Bonni for
critical reading of the manuscript, and Dr. DeGregori for sharingated anti-CD8 antibodies and streptavidin-coated superparamag-
netic beads (Dynabeads M-280, Dynal) and negatively selected unpublished information prior to submission of a manuscript.
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(1 
Ci/100 
l) was added, and proliferation was measured 16 hr from the Basque Department of Education, and by Grant 98/0562
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